183 related articles for article (PubMed ID: 27874035)
1. p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming.
Gong L; Pan X; Chen H; Rao L; Zeng Y; Hang H; Peng J; Xiao L; Chen J
Sci Rep; 2016 Nov; 6():37281. PubMed ID: 27874035
[TBL] [Abstract][Full Text] [Related]
2. Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.
Horikawa I; Park KY; Isogaya K; Hiyoshi Y; Li H; Anami K; Robles AI; Mondal AM; Fujita K; Serrano M; Harris CC
Cell Death Differ; 2017 Jun; 24(6):1017-1028. PubMed ID: 28362428
[TBL] [Abstract][Full Text] [Related]
3. p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage.
Gong L; Gong H; Pan X; Chang C; Ou Z; Ye S; Yin L; Yang L; Tao T; Zhang Z; Liu C; Lane DP; Peng J; Chen J
Cell Res; 2015 Mar; 25(3):351-69. PubMed ID: 25698579
[TBL] [Abstract][Full Text] [Related]
4. p73 coordinates with Δ133p53 to promote DNA double-strand break repair.
Gong H; Zhang Y; Jiang K; Ye S; Chen S; Zhang Q; Peng J; Chen J
Cell Death Differ; 2018 Jun; 25(6):1063-1079. PubMed ID: 29511339
[TBL] [Abstract][Full Text] [Related]
5. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.
Jiang J; Lv W; Ye X; Wang L; Zhang M; Yang H; Okuka M; Zhou C; Zhang X; Liu L; Li J
Cell Res; 2013 Jan; 23(1):92-106. PubMed ID: 23147797
[TBL] [Abstract][Full Text] [Related]
6. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.
Marión RM; Strati K; Li H; Murga M; Blanco R; Ortega S; Fernandez-Capetillo O; Serrano M; Blasco MA
Nature; 2009 Aug; 460(7259):1149-53. PubMed ID: 19668189
[TBL] [Abstract][Full Text] [Related]
7. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence.
Fujita K; Mondal AM; Horikawa I; Nguyen GH; Kumamoto K; Sohn JJ; Bowman ED; Mathe EA; Schetter AJ; Pine SR; Ji H; Vojtesek B; Bourdon JC; Lane DP; Harris CC
Nat Cell Biol; 2009 Sep; 11(9):1135-42. PubMed ID: 19701195
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells.
Kinoshita T; Nagamatsu G; Kosaka T; Takubo K; Hotta A; Ellis J; Suda T
Biochem Biophys Res Commun; 2011 Apr; 407(2):321-6. PubMed ID: 21385566
[TBL] [Abstract][Full Text] [Related]
9. Δ133p53: A p53 isoform enriched in human pluripotent stem cells.
Horikawa I; Harris CC
Cell Cycle; 2017 Sep; 16(18):1631-1632. PubMed ID: 28727499
[No Abstract] [Full Text] [Related]
10. MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling.
Ye D; Wang G; Liu Y; Huang W; Wu M; Zhu S; Jia W; Deng AM; Liu H; Kang J
Stem Cells; 2012 Aug; 30(8):1645-54. PubMed ID: 22696098
[TBL] [Abstract][Full Text] [Related]
11. p53-facilitated miR-199a-3p regulates somatic cell reprogramming.
Wang J; He Q; Han C; Gu H; Jin L; Li Q; Mei Y; Wu M
Stem Cells; 2012 Jul; 30(7):1405-13. PubMed ID: 22553189
[TBL] [Abstract][Full Text] [Related]
12. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
[TBL] [Abstract][Full Text] [Related]
13. Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage.
Rasmussen MA; Holst B; Tümer Z; Johnsen MG; Zhou S; Stummann TC; Hyttel P; Clausen C
Stem Cell Reports; 2014 Sep; 3(3):404-13. PubMed ID: 25241739
[TBL] [Abstract][Full Text] [Related]
14. Transactivation domain of p53 regulates DNA repair and integrity in human iPS cells.
Kannappan R; Mattapally S; Wagle PA; Zhang J
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H512-H521. PubMed ID: 29775409
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
Yi L; Lu C; Hu W; Sun Y; Levine AJ
Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
[TBL] [Abstract][Full Text] [Related]
16. Effects of reprogramming on genomic imprinting and the application of pluripotent stem cells.
Li X; Li MJ; Yang Y; Bai Y
Stem Cell Res; 2019 Dec; 41():101655. PubMed ID: 31734645
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced astrocyte senescence is rescued by Δ133p53.
Turnquist C; Beck JA; Horikawa I; Obiorah IE; Von Muhlinen N; Vojtesek B; Lane DP; Grunseich C; Chahine JJ; Ames HM; Smart DD; Harris BT; Harris CC
Neuro Oncol; 2019 Mar; 21(4):474-485. PubMed ID: 30615147
[TBL] [Abstract][Full Text] [Related]
18. Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript.
Marcel V; Perrier S; Aoubala M; Ageorges S; Groves MJ; Diot A; Fernandes K; Tauro S; Bourdon JC
FEBS Lett; 2010 Nov; 584(21):4463-8. PubMed ID: 20937277
[TBL] [Abstract][Full Text] [Related]
19. Genomic stability in reprogramming.
Ronen D; Benvenisty N
Curr Opin Genet Dev; 2012 Oct; 22(5):444-9. PubMed ID: 23040504
[TBL] [Abstract][Full Text] [Related]
20. p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter.
Marcel V; Vijayakumar V; Fernández-Cuesta L; Hafsi H; Sagne C; Hautefeuille A; Olivier M; Hainaut P
Oncogene; 2010 May; 29(18):2691-700. PubMed ID: 20190805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
